Correlation assessment of Perfusion quantification with Fluobeam and operative outcome in prepectoral implant breast reconstruction: single center, open, prospective observational study
- Conditions
- Neoplasms
- Registration Number
- KCT0007054
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
All patients can participate in this study only if they meet all of the following criteria.
(1) Patients over 19 years of age
(2) Patients who need total mastectomy for breast cancer
(3) Patients undergoing immediate two-stage implant breast reconstruction after total mastectomy (skin preservation) is performed.
(4) Patients who use Acelluar Dermal Matrix for breast reconstruction
(5) Patients who need radiotherapy after breast reconstruction
(6) Patients who agree to participate in the study and can be followed up within the study period
Patients with any of the following criteria were excluded from this study.
(1) A patient undergoing chemotherapy for cancer other than breast cancer
(2) Patients with confirmed local recurrence or systemic metastasis of breast cancer
(3) Patients with underlying conditions such as infectious diseases, systemic autoimmune diseases (especially rheumatoid diseases, etc.), and blood coagulation disorders
(4) Patients with systemic diseases other than breast cancer
(5) Pregnant women or lactating women
(6) Other patients who were judged to be difficult to participate in this study by the investigator
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Skin condition evaluation;Complication evaluation
- Secondary Outcome Measures
Name Time Method Capsular Contracture;patient satisfaction evaluation